Cephalosporin-resistant gonorrhea in North America
- PMID: 23299612
- PMCID: PMC6749818
- DOI: 10.1001/jama.2012.205107
Cephalosporin-resistant gonorrhea in North America
Conflict of interest statement
Comment in
-
Cephalosporin resistance in Neisseria gonorrhoeae infections.JAMA. 2013 May 15;309(19):1989. doi: 10.1001/jama.2013.4078. JAMA. 2013. PMID: 23677303 No abstract available.
-
Cephalosporin resistance in Neisseria gonorrhoeae infections--reply.JAMA. 2013 May 15;309(19):1990-1. doi: 10.1001/jama.2013.4084. JAMA. 2013. PMID: 23677305 Free PMC article. No abstract available.
Comment on
-
Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.JAMA. 2013 Jan 9;309(2):163-70. doi: 10.1001/jama.2012.176575. JAMA. 2013. PMID: 23299608
References
-
- Global incidence and prevalence of selected curable sexually transmitted infections: 2008 World Health Organization. http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimat.... Accessed December 17, 2012.
-
- Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2011. Atlanta, GA: US Dept of Health & Human Services; 2012.
-
- Weinstock HS, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6–10. - PubMed
-
- Braunstein SL, Ingabire CM, Kestelyn E, et al. High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm Dis. 2011; 38(5):385–394. - PubMed
-
- Centers for Disease Control and Prevention (CDC). Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332–336. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
